![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 9, 6748-6754, February 28, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the a Garvan Institute of Medical
Research, Darlinghurst, Sydney 2010, Australia, b Prince of
Wales Medical Research Institute, Randwick 2031, Australia,
c University of New South Wales, Sydney 2052, Australia, d Centre for Education and Research on
Ageing, University of Sydney and Concord Repatriation General Hospital,
Concord 2139, Australia, e Department of Human Genetics,
Mount Sinai School of Medicine, New York, New York 10029, f Neurotec, Section of Experimental Geriatrics, Karolinska
Institute, Stockholm S-141 86, Sweden, g Laboratory for
Alzheimer's Disease, Brain Science Institute, Riken, Saitama 350-01, Japan, h Department of Pathology, University of
Tasmania, Hobart, 7001, Australia, and i Farber Institute
for Neuroscience, Thomas Jefferson University, Philadelphia,
Pennsylvania 19107
The mutation L271V in exon 8 of the presenilin-1 (PS-1) gene was detected in an Alzheimer's
disease pedigree. Neuropathological examination of affected
individuals identified variant, large, non-cored plaques without
neuritic dystrophy, reminiscent of cotton wool plaques. Biochemical
analysis of L271V mutation showed that it increased secretion of the
42-amino acid amyloid-
Presenilin-1 Mutation L271V Results in Altered Exon 8 Splicing and Alzheimer's Disease with Non-cored Plaques and No
Neuritic Dystrophy*
peptide, suggesting a pathogenic mutation.
Analysis of PS-1 transcripts from the brains of two mutation carriers
revealed a 17-50% increase in PS-1 transcripts with deletion of exon
8 (PS-1
exon8) compared with unrelated Alzheimer's disease brains.
Exon trapping analysis confirmed that L271V mutation enhanced the
deletion of exon 8. Western blots of brain lysates indicated that
PS-1
exon8 was overexpressed in an affected individual. Biochemical
analysis of PS-1
exon8 in COS and BD8 cells indicate the splice
isoform is not intrinsically active but interacts with wild-type PS-1
to generate amyloid-
. Western blots of cell lysates
immunoprecipitated with anti-Tau or anti-GSK-3
antibodies indicated
that PS-1
exon8, unlike wild-type PS-1, does not interact directly
with Tau or GSK-3
, potential modifiers of neuritic dystrophy. We
postulate that variant plaques observed in this family are due in part
to the effects of PS-1
exon8 and that interaction between PS-1 and
various protein complexes are necessary for neuritic plaque formation.
*
This work was supported by Department of Veteran Affairs
(Australia) Grant 9937441 (to J. B. J. K., W. S. B., and
P. R. S.), National Health and Medical Research Council (Australia)
grants, Project Fellowship Grant 113804 (to G. M. H.), Block
Grant 993050 (to P. R. S.), Network Grant 983302 (to J. B. J. K.,
W. S. B., and P. R. S.), and National Institutes of Health Grant
NIA AG10491 (to S. E. G. and R. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
S. Nornes, M. Newman, G. Verdile, S. Wells, C. L. Stoick-Cooper, B. Tucker, I. Frederich-Sleptsova, R. Martins, and M. Lardelli Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity Hum. Mol. Genet., February 1, 2008; 17(3): 402 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhao, M. Yu, M. Neitzel, J. Marugg, J. Jagodzinski, M. Lee, K. Hu, D. Schenk, T. Yednock, and G. Basi Identification of {gamma}-Secretase Inhibitor Potency Determinants on Presenilin J. Biol. Chem., February 1, 2008; 283(5): 2927 - 2938. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Arrisi-Mercado, M. Romano, A. F. Muro, and F. E. Baralle An Exonic Splicing Enhancer Offsets the Atypical GU-rich 3' Splice Site of Human Apolipoprotein A-II Exon 3 J. Biol. Chem., September 17, 2004; 279(38): 39331 - 39339. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Schroeter, Ma. X. G. Ilagan, A. L. Brunkan, S. Hecimovic, Y.-m. Li, M. Xu, H. D. Lewis, M. T. Saxena, B. De Strooper, A. Coonrod, et al. A presenilin dimer at the core of the {gamma}-secretase enzyme: Insights from parallel analysis of Notch 1 and APP proteolysis PNAS, October 28, 2003; 100(22): 13075 - 13080. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |